Back to KRYS

Avoro Capital Advisors LLC → KRYS

Avoro Capital Advisors LLC KRYS Position History

Krystal Biotech, Inc. • Healthcare

Quarters held
5
Latest value
$960.7M
Q3 2026
Peak value
$1.1B
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$712.2M
Q4 2025$712.2M
Q1 2026$746.3M
Q2 2026$1.1B
Q3 2026$960.7M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$960.7M2.89M——
Q2 2026$1.1B2.89M——
Q1 2026$746.3M2.89M——
Q4 2025$712.2M2.89M——
Q4 2025$712.2M2.89M——

Other funds holding KRYS

Other Avoro Capital Advisors LLC positions

UTHR

UNITED THERAPEUTICS CORP

$1.6B
UTHR

UNITED THERAPEUTICS CORP

$1.5B
UTHR

UNITED THERAPEUTICS CORP

$1.5B
ASND

ASCENDIS PHARMA

$1.4B
UTHR

UNITED THERAPEUTICS CORP

$1.3B
UTHR

UNITED THERAPEUTICS CORP

$1.3B
ASND

ASCENDIS PHARMA

$1.2B
ASND

ASCENDIS PHARMA A/S

$1.2B